Emergent BioSolutions EBS
NYSE EBS
$6.16 -0.20 (-3.14%)
As of: Oct 20, 2026 · 10:02 AM EDT

Emergent BioSolutions (EBS) Current Debt (2019 - 2024)

Updated

Analysis

Emergent BioSolutions (EBS) Current Debt (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,155.24 Bn 1,123.83 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 623.42 Bn 541.95 Bn 17.26 Bn -5.75 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn -
4 Merck 365.56 Bn 319.94 Bn 12.21 Bn -
5 Novartis Ag 295.87 Bn 259.86 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 260.01 Bn 233.70 Bn 12.86 Bn -
7 Amgen 234.60 Bn 190.00 Bn 7.24 Bn -
8 Gilead Sciences 193.70 Bn 167.90 Bn 6.22 Bn -
9 Pfizer 171.34 Bn 117.99 Bn 10.94 Bn 64.00 Mn
10 Emergent BioSolutions 316.05 Mn -434.85 Mn 137.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -222.70 Mn
Jun 30, 2024 -56.50 Mn
Mar 31, 2024 -5.00 Mn
Dec 31, 2023 -12.00 Mn
Sep 30, 2023 -39.00 Mn
Jun 30, 2023 -347.80 Mn
Sep 30, 2020 -353.00 Mn
Mar 31, 2020 -20.00 Mn
Dec 31, 2019 -10.00 Mn
Sep 30, 2019 -15.00 Mn
Jun 30, 2019 100.00 Mn
Mar 31, 2019 -50.00 Mn
API Access

Emergent BioSolutions Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY